Generic Rythmol SR Availability
Last updated on Jun 11, 2025.
See also: Generic Rythmol
Rythmol SR is a brand name of propafenone, approved by the FDA in the following formulation(s):
RYTHMOL SR (propafenone hydrochloride - capsule, extended release;oral)
-
Manufacturer: GLAXOSMITHKLINE LLC
Approval date: September 4, 2003
Strength(s): 225MG (discontinued) [RLD], 325MG (discontinued) [RLD], 425MG (discontinued) [RLD]
All of the above formulations have been discontinued.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Rythmol SR. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: Generic Drug FAQ.
More about Rythmol SR (propafenone)
- Rythmol SR consumer information
- Check interactions
- Compare alternatives
- Reviews (17)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: group I antiarrhythmics
- Breastfeeding
Related treatment guides
Related/similar drugs
Xarelto
Xarelto (rivaroxaban) is a factor Xa inhibitor used to reduce the risk of blood clots and stroke in ...
Cardizem
Cardizem is used to treat hypertension (high blood pressure), angina (chest pain), and heart rhythm ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Lanoxin
Lanoxin (digoxin) is used to treat congestive heart failure and atrial fibrillation. Includes ...
Multaq
Multaq (dronedarone) is an antiarrhythmic medication used to treat atrial fibrillation and atrial ...
Edoxaban
Edoxaban is used for atrial fibrillation, deep vein thrombosis, prevention of thromboembolism in ...
Sotalol
Sotalol is a beta-blocker with antiarrhythmic properties that affects the heart and circulation ...
Flecainide
Flecainide is used for atrial fibrillation, atrial flutter, paroxysmal supraventricular ...
Rivaroxaban
Rivaroxaban is used for atrial fibrillation, cardiovascular risk reduction, congenital heart ...
Glossary
| Term | Definition |
|---|---|
| Drug Patent | A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation. |
| Drug Exclusivity | Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant. |
| RLD | A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
